Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "Monolith"

LOS ANGELES, CA--(Marketwired - Mar 31, 2014) - Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the Shasta GenStrip™, the Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that its Pharma Tech Solutions subsidiary has completed and will air in many regions in the U.S. its new commercial video titled "GenStrip: Monolith." The video is available for viewing at:

http://shastagenstrip.com/winter_ad.html or http://youtu.be/10sOaLxGvjQ

The company will publish a media schedule for GenStrip: "Monolith" just as soon as all previously purchased commercial spots for the GenStrip "A Patchwork of Life" spots are completed. The new GenStrip commercial will be played in most metropolitan areas beginning April 5, 2014. Time has also been booked from a nationwide service for the local hours of 1:00 pm through 6:00 pm. However, the bulk of the 12,500 purchased commercial plays for thirty days beginning April 5, 2014 will be via saturated cable television buys during late at night hours, a time tested method used for diabetes and over-the-counter pharmaceutical products.

DECN is also a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill and a premier developer of revolutionary cell phone centric e-health products and technologies. DECN's GenStrip™ product was cleared by the U.S. FDA in November 2012, and after several successful long running legal battles with a division of Johnson & Johnson, Genstrip was finally introduced to the market in late 2013 as a lower cost (60%) alternative for user/owners of Johnson and Johnson LifeScan OneTouch^® Ultra^®, Ultra2^® and Ultra Mini^® glucose meters.

Forward-Looking Statements:
This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates," "will" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions.

For further information about Shasta GenStrip, please visit the company's Web Sites: http://www.decisiondiagnostics.com or http://www.shastagenstrip.com or www.pharmatechdirect.com.

GenStrip^™ test strips are a product of Pharma Tech Solutions, Inc. and are not manufactured, distributed, endorsed, or approved by, nor associated with, LifeScan®, Inc. a Johnson & Johnson® Company, manufacturers and distributors of the OneTouch® Ultra® Family of meters and OneTouch® Ultra® test strips.

Contact:
Decision Diagnostics Corp.
Keith Berman
[phone]
[e-mail]